The Department of Pediatrics

Pediatric Specialty Center of Saint Barnabas

Department Physicians

Dennis Brenner, M.D.
Division Chief

Dr. Dennis Brenner graduated from the State University of New York Downstate School of Medicine in Brooklyn, New York and attended residency and fellowship at Schneider Children’s Hospital at Long Island Jewish Medical Center. He then worked for four years at Baystate Children’s Hospital in Springfield, Massachusetts as both a pediatric endocrinologist and an Associate Medical Director for Clinical Informatics before joining Saint Barnabas in December, 2007. He is Board Certified in Pediatric Endocrinology.

To request an appointment for Dr. Dennis Brenner, please visit our Physician Search site.

Publications / Poster Presentations

1. Optimal Hyperlipidemia Monitoring in Children and Adolescents with Type 1 Diabetes Mellitus. Allen HA, Brenner D, Reiter O. Poster Presentation, Lawson Wilkins Pediatric Endocrine Society Meeting, Honolulu, Hawaii, May 2008

2. Prospective Detection Of Hyperglycemia In Critically Ill Children Using Continuous Glucose Monitoring. Allen HF, Rake A, Roy M, Brenner D, McKiernan CA. Pediatric Critical Care Medicine. 9(2):153-158, March 2008.

3. Association Between Phone Contact And Inter-visit Glycemic Control In Type 1 Diabetic Children. Brenner D, Ben-Chaim A, Allen HF, Reiter EO. Presented at American Diabetes Association Scientific Session, Chicago, IL, June 22-24, 2007.

4. Does Increased BMI Impair Predicted Adult Height in Female Patients Treated with Depot GnRH for Precocious Puberty? Morneault E, Allen HA, Brenner D, Poster presentation, Lawson Wilkins Pediatric Endocrine Society Meeting, Toronto, Canada, May 7, 2007.

5. Birth Weight Percentiles in Obese Hyperinsulinemic and Obese Hyperandrogenemic Adolescent Females Compared to Obese Controls. Brenner D, Allen HF, Reiter EO. Poster presentation, Endocrine Society Annual Meeting, Boston, MA, June 2006.

6. Assessment of Body Composition in Girls treated for Precocious Puberty with GnRH Agonists. Brenner D, Allen HF, Reiter EO. Poster presentation, ESPE-LWPES joint meeting, Lyon, France, September 2005.

7. A randomized controlled trial of OCP vs OCP with metformin in adolescents with PCOS. Allen HF, Brenner D, Reiter, EO. Poster presentation, ESPE-LWPES joint meeting, Lyon, France, September 2005.

8. Parental Attitudes about Hypoglycemia in Type I Diabetics. Brenner D, Carey DE, Frank GR, Kreitzer P. Poster presentation, Endocrine Society Annual Meeting, San Diego, CA, June 2005.

9. Acquired Abnormalities of The Hypothalamic-Pituitary Axis Leading To Growth Impairment. Brenner DJ, Reiter EO. Chapter, in “Clinical Pediatric Endocrinology” 5th Edition, Blackwell Publishing, 2005 Edited by Charles Brook.

10. Immunoregulatory T Cell Population In New-onset Type I Diabetic Children Compared To That Of Normal Children. Brenner DJ, McCloskey TW, Pahwa S, Speiser PW Poster presentation, Endocrine Society Annual Meeting, New Orleans, LA, June 2004.

11. Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency. Speiser PW, Brenner DJ. Endocrinologist. 13(4):334-340, July/August 2003.

12. Successful Computerization of a Hospital-Based Pediatric Endocrinology Practice. Brenner DJ, Carey DE, Frank GR, Fort P, Kreitzer PK, Speiser PW Poster presentation, Lawson Wilkins Pediatric Endocrine Society Meeting, Baltimore, MD, May 2002.

13. Precocious Puberty in Rubinstein-Taybi Syndrome. Brenner DJ, Speiser PW. Poster presentation, Endocrine Society Annual Meeting, Denver, CO, June, 2001.

14. Profiles of obese children presenting for metabolic evaluation. Anavian J, Brenner DJ, Fort P, Speiser PW. Journal of Pediatric Endocrinology and Metabolism 2001 Sep Oct;14(8):1145-50

Research (While at Baystate Children’s Hospital, Springfield, MA)

• Principal investigator, Pfizer “Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature”

• Principal investigator , Insmed, “Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome”

• Sub-investigator, Tercica, “Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) treatment of pre-pubertal children with growth failure associated with primary IGF-1 Deficiency, An Open Label Multi Center, Extension Study”

• Sub-investigator, Novo-Nordisk, “Norditropin National Registry protocol”

• Sub-investigator, Pfizer, “KIGS Registry for Growth Hormone Therapy”

• Sub-investigator, Genentech “A Postmarketing Surveillance Program for Nutropin, Nutropin AQ, and Protropin”

Speaking Engagements

1. “Medical Complications of  Type 2 diabetes”, JFK Medical Center, Edison, NJ, October 2008

2. “The Posterior Pituitary.” Pediatric Grand  Rounds, Newark Beth Israel Medical Center, October 2008.

3. “Costs and Benefits of EMR implementation” Lawson Wilkens Pediatric Endocrinology Society Annual Meeting, Toronto, Canada, May 6, 2007.

4. “The Posterior Pituitary.” Pediatric Grand  Rounds, Baystate Children’s Hospital, Springfield, MA, August, 2006.

5. “Precocious Puberty.” Reproductive Endocrinology Grand Rounds, Baystate Medical Center, Springfield, MA April 2006.

6. “Computerization of the pediatric endocrinology practice” Hackensack University Medical Center, Hackensack, NJ, April 7, 2005.

7. “Treatment of Small for Gestational Age Infants with Growth Hormone”, Springfield, MA, March 29, 2005.

8. “Recognition and Treatment of Diabetic Ketoacidosis.” Pediatric Grand  Rounds, Baystate Medical Center, August 31, 2004.

9. “Doctors on call: Pediatric Diabetes.” WGBY, Public Broadcasting Service, Springfield, MA, March 23, 2004.

10. “Transition from Pediatric to Adult Endocrine Care.” Adult Endocrinology Grand Rounds, Baystate Medical Center, December 30, 2003.

To request an appointment for Dr. Dennis Brenner, please visit our Physician Search site.